These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Early emergence of three dopamine D1 receptor subtypes in vertebrates. Molecular phylogenetic, pharmacological, and functional criteria defining D1A, D1B, and D1C receptors in European eel Anguilla anguilla. Cardinaud B, Sugamori KS, Coudouel S, Vincent JD, Niznik HB, Vernier P. J Biol Chem; 1997 Jan 31; 272(5):2778-87. PubMed ID: 9006917 [Abstract] [Full Text] [Related]
8. Characteristics of stably expressed human dopamine D1a and D1b receptors: atypical behavior of the dopamine D1b receptor. Pedersen UB, Norby B, Jensen AA, Schiødt M, Hansen A, Suhr-Jessen P, Scheideler M, Thastrup O, Andersen PH. Eur J Pharmacol; 1994 Mar 15; 267(1):85-93. PubMed ID: 8206133 [Abstract] [Full Text] [Related]
13. NNC-112, NNC-687 and NNC-756, new selective and highly potent dopamine D1 receptor antagonists. Andersen PH, Grønvald FC, Hohlweg R, Hansen LB, Guddal E, Braestrup C, Nielsen EB. Eur J Pharmacol; 1992 Aug 14; 219(1):45-52. PubMed ID: 1397049 [Abstract] [Full Text] [Related]
14. Dopamine D1A receptors and renin release in rat juxtaglomerular cells. Yamaguchi I, Yao L, Sanada H, Ozono R, Mouradian MM, Jose PA, Carey RM, Felder RA. Hypertension; 1997 Apr 14; 29(4):962-8. PubMed ID: 9095084 [Abstract] [Full Text] [Related]
15. Characterization of the binding of SCH 39166 to the five cloned dopamine receptor subtypes. Tice MA, Hashemi T, Taylor LA, Duffy RA, McQuade RD. Pharmacol Biochem Behav; 1994 Nov 14; 49(3):567-71. PubMed ID: 7862709 [Abstract] [Full Text] [Related]
16. Chimeric D1/D2 dopamine receptors. Distinct determinants of selective efficacy, potency, and signal transduction. Kozell LB, Machida CA, Neve RL, Neve KA. J Biol Chem; 1994 Dec 02; 269(48):30299-306. PubMed ID: 7982941 [Abstract] [Full Text] [Related]
17. Silencing of the constitutive activity of the dopamine D1B receptor. Reciprocal mutations between D1 receptor subtypes delineate residues underlying activation properties. Charpentier S, Jarvie KR, Severynse DM, Caron MG, Tiberi M. J Biol Chem; 1996 Nov 08; 271(45):28071-6. PubMed ID: 8910419 [Abstract] [Full Text] [Related]
18. 9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: a potent full dopamine D1 agonist containing a rigid-beta-phenyldopamine pharmacophore. Ghosh D, Snyder SE, Watts VJ, Mailman RB, Nichols DE. J Med Chem; 1996 Jan 19; 39(2):549-55. PubMed ID: 8558526 [Abstract] [Full Text] [Related]
19. A primordial dopamine D1-like adenylyl cyclase-linked receptor from Drosophila melanogaster displaying poor affinity for benzazepines. Sugamori KS, Demchyshyn LL, McConkey F, Forte MA, Niznik HB. FEBS Lett; 1995 Apr 03; 362(2):131-8. PubMed ID: 7720859 [Abstract] [Full Text] [Related]
20. 11C- and 76Br-labelled NNC 22-0010, selective dopamine D1 receptor radioligands for PET. Foged C, Halldin C, Loc'h C, Mazière B, Karlsson P, Mazière M, Swahn CG, Farde L. Nucl Med Biol; 1996 Aug 03; 23(6):837-44. PubMed ID: 8940728 [Abstract] [Full Text] [Related] Page: [Next] [New Search]